Drug comparisons
Insulin Icodec vs Lixisenatide
Insulin Icodec is basal insulin for glucose control while Lixisenatide is GLP-1 agonist for post-meal control. Which is better depends on your diabetes needs.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered when evaluating basal insulin therapy versus GLP-1 receptor agonist options for patients with type 2 diabetes not at goal on oral medications.
Bottom line
The better medication between Insulin Icodec and Lixisenatide depends on individual patient characteristics and is not a one-size-fits-all choice.
All medication comparisons